Possible Differences in HCC Course Depending on DAA Treatment

NCT05376943 · clinicaltrials.gov ↗

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Hepatocellular
Hepatitis C Virus Infection, Response to Therapy of
Drug Effect
Drug Side Effect
Hepatitis C, Chronic
Liver Cirrhosis

Interventions

DRUG: Direct Acting Antivirals

Sponsor

Medical University of Warsaw